MedPath

Methylprednisolone hemisuccinate

Generic Name
Methylprednisolone hemisuccinate
Brand Names
Solu-medrol
Drug Type
Small Molecule
Chemical Formula
C26H34O8
CAS Number
2921-57-5
Unique Ingredient Identifier
5GMR90S4KN

Overview

A water-soluble ester of methylprednisolone used for cardiac, allergic, and hypoxic emergencies.

Background

A water-soluble ester of methylprednisolone used for cardiac, allergic, and hypoxic emergencies.

Indication

No indication information available.

Associated Conditions

  • Acute Gouty Arthritis
  • Ankylosing Spondylitis (AS)
  • Berylliosis
  • Congenital Adrenal Hyperplasia (CAH)
  • Congenital Hypoplastic Anemia
  • Dermatitis bullous
  • Dermatomyositis (DM)
  • Edema of the cerebrum
  • Hypercalcemia of Malignancy
  • Immune Thrombocytopenia (ITP)
  • Leukemias
  • Lymphoma
  • Multiple sclerosis exacerbation
  • Mycosis Fungoides (MF)
  • Ophthalmia, Sympathetic
  • Pemphigus
  • Polymyositis
  • Primary adrenocortical insufficiency
  • Psoriatic Arthritis
  • Pure Red Cell Aplasia
  • Refractory Uveitis
  • Regional Enteritis
  • Rheumatoid Arthritis
  • Secondary adrenocortical insufficiency
  • Secondary thrombocytopenia
  • Stevens-Johnson Syndrome
  • Systemic Lupus Erythematosus
  • Temporal Arteritis
  • Trichinosis
  • Tuberculous Meningitis
  • Ulcerative Colitis
  • Acquired immune hemolytic anemia
  • Acute rheumatic carditis
  • Disseminated Pulmonary Tuberculosis (TB)
  • Exfoliative erythroderma
  • Fulminating Pulmonary Tuberculosis
  • Idiopathic eosinophilic pneumonias
  • Non-suppurative Thyroiditis
  • Severe Allergic Reactions
  • Symptomatic Sarcoidosis

FDA Approved Products

Methylprednisolone
Manufacturer:Asclemed USA, Inc.
Route:ORAL
Strength:4 mg in 1 1
Approved: 2022/10/12
NDC:76420-041
Methylprednisolone
Manufacturer:Unit Dose Services
Route:ORAL
Strength:4 mg in 1 1
Approved: 2017/12/07
NDC:70786-0001
METHYLPREDNISOLONE
Manufacturer:REMEDYREPACK INC.
Route:ORAL
Strength:4 mg in 1 1
Approved: 2024/03/07
NDC:70518-2864
SOLU-MEDROL
Manufacturer:Pharmacia & Upjohn Company LLC
Route:INTRAVENOUS, INTRAMUSCULAR
Strength:2 g in 30.6 mL
Approved: 2024/01/04
NDC:0009-0850
Methylprednisolone Sodium Succinate
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAVENOUS, INTRAMUSCULAR
Strength:40 mg in 1 mL
Approved: 2020/03/17
NDC:63323-255

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath